Biotech & Life Sciences
Atoll Financial Group es una compañía de servicios financieros, con sede en Washington DC, especializada en prestar asistencia a empresas públicas y privadas en la obtención de fondos en el mercado de capitales para la implementación de proyectos multimillonarios y a largo plazo.
​
Ya sea que su visión comercial necesita el financiamiento de proyectos, fondos de capital de riesgo, inversión de capital social u otro tipo de fondos de inversión, nuestra cobertura es global e incluye una amplia gama de segmentos dentro de la industria.
​
Nuestra fortaleza proviene de nuestro conocimiento a fondo de la industria, relaciones constantes y perdurables con distintas fuentes de financiamiento muy diversificadas y un talentoso equipo que comparte la misma mentalidad centrada en la búsqueda de soluciones. Como promotores de su proyecto, le ofrecemos el instrumento financiero más competitivo y podemos hacerlo porque trabajamos directamente con un diverso grupo de inversionistas y prestamistas. Es a través de una cultura de rendición de cuentas y un compromiso mutuo con la excelencia que logramos satisfacer sus necesidades financieras.
Lower and Lower-Middle Market Companies
Team
Dr. Sergio Botero
Lead Advisor
Biotech & Life Sciences
Sergio Botero is both a strategist and a scientist bringing a broad range of scientific and engineering expertise to Atoll by bridging technical and financial aspects of projects. Sergio’s academic background started with two Bachelors of Science degrees, in Biology and Microbiology, and a Master of Science degree in Biological Sciences with emphasis on Ecology and Primatology, all at Universidad de los Andes in his home country of Colombia. >>>
​
Jin Young Kim
Research Associate
Biotech & Life Sciences
Jin Young Kim is a Ph.D. candidate in Molecular and Cell Biology at University of California, Berkeley, where she developed a novel CRISPRi-based method using RNA barcodes to investigate genetic regulators of human genes and mRNAs. She earned her Bachelor of Science degree in Biochemistry and Cell Biology from Rice University, where she conducted research in synthetic biology, engineering proteins, and developing biological sensors. >>>>​​​
José Estabil
Strategic Advisor
Biotech & Life Sciences
José Estabil is a connector and technology innovator in the life sciences. His recent executive roles focus on AI-assisted precision medicine. José translated cutting edge genomics and optics into profitable molecular diagnostics (Cipherome), chip diagnostics (KLA), and semiconductor devices (IBM) that resulted in reducing the risk of leg amputations, cost-effective semiconductor manufacturing, and faster circuits, respectively. >>>>
​
​​
Wei-Yu Chi
Research Associate
Biotech & Life Sciences
Wei-Yu Chi is a medical doctor and current Ph.D. candidate at Weill Cornell Medicine, specializing in the development of single-cell sequencing technologies. With a focus on oncology, he is pioneering a novel sequencing method to profile transcription factor binding in single cells—a critical advance for understanding blood cancers such as leukemia and lymphoma and identifying potential drug targets. >>>>​​​
​
Dr. Mohammed Mostajo-Radji
Business Development Advisor
Biotech & Life Sciences
Dr. Mohammed Mostajo-Radji is an Assistant Research Scientist at the Genomics Institute of the University of California, Santa Cruz (UCSC), where his lab is part of the Braingeneers group, a multidisciplinary collective of geneticists, neuroscientists, and engineers focused on understanding the specification and function of the human brain. >>>>​​​
​
​
JJ Carrasco
Managing Partner
A visionary and veteran of the financial industry, JJ Carrasco established Atoll Financial Group to meet the unique needs of businesses looking for innovative structured project finance and other complex financing alternatives. As Managing Partner, JJ is responsible for the overall company strategy and management of all business processes, strategic partnerships, product development and market feasibility analysis, staffing, and more. >>>
Lauren Dierdorff
Research Associate
Biotech & Life Sciences
Lauren Dierdorff is a Ph.D. candidate in Neuroscience at the Icahn School of Medicine at Mount Sinai, conducting translational research in the De Rubeis lab within the Seaver Autism Center for Research and Treatment and Department of Psychiatry. Her work focuses on the cortical circuits underlying motor deficits in a model of DDX3X syndrome, a rare genetic neurodevelopmental disorder. >>>>
​
​​
Jonathan Hakala
Partner | Managing Director of Capital Markets
As Managing Director of Capital Markets, Jonathan Hakala brings a wealth of senior financial, managerial and board-level experience to this leadership position helping to oversee capital markets activities for the Atoll Financial Group. Jonathan's senior financial, managerial and board-level expertise helps the Atoll Financial Group team pursue the best possible financial solutions for our clients. >>>